FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

DIVISLAB

2,470
+48.85 (2.02%)
Updated 03:29 05/06 IST

DIVISLAB Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 921,500 for DIVISLAB
Disclaimer
100% Bullish
0% Bearish

DIVISLAB Ratings

Long term DIVISLAB rating by FrontPage users
4/5 (4 Ratings)
Find answers to all your questions on live DIVISLAB message board: Is DIVISLAB buy or sell? Should I buy DIVISLAB shares? Why are DIVISLAB shares falling? Should I invest in DIVISLAB stock?

DIVISLAB Share Price Discussion

M
Reputation: -1,056 • Jun 3 5:32 AM

Type
Buy
Instrument
DIVISLAB JUN20 FUT
Entry Price
₹2,410
Price@Trade
₹2,413.8
Target Price
₹2,500
Stop Price
₹2,360
Valid Till
Jun 3, 2020 3:20 AM
Margin
₹447,664.8 approx for 800 Qty
Status
Validity Over
Exit Price
₹2,389.1
Net P&L
-₹16,720 (-3.73%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 3 5:40 AM

Update
Trade Entered
Entry Price
₹2,410
TrackerBot @trackerbot
Jun 3 8:50 AM

Update
Validity Over
Exit Price
₹2,389.1
Net P&L
-₹16,720 (-3.73%)
Reputation: 158 • Jun 2 12:18 PM
Post by ChartArt in DIVISLAB community on FrontPage
#ChartArt #EducationalPurposes #DIVISLAB #Bullish CMP 2480
FrontPage
Like
Reply

Type
Sell
Instrument
DIVISLAB
Entry Price
₹2,483.85
Price@Trade
₹2,483.85
Target Price
₹2,397.65
Stop Price
₹2,520.5
Valid Till
Jun 2, 2020 3:20 AM
Margin
₹99,354 approx for 40 Qty
Status
Exited
Exit Price
₹2,440
Net P&L
+₹1,754 (+1.77%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹2,440
Net P&L
+₹1,754 (+1.77%)
R
Reputation: 3,404 • Jun 2 2:56 AM

Type
Buy
Instrument
DIVISLAB JUN20 FUT
Entry Price
₹2,530.25
Price@Trade
₹2,526.1
Target Price
₹3,200
Stop Price
₹2,000
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹921,500 approx for 1600 Qty
Status
Active
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jun 2 2:57 AM

Update
Trade Entered
Entry Price
₹2,530.25
R
Reputation: 3,404 • Jun 2 2:54 AM

Type
Buy
Instrument
DIVISLAB JUN20 FUT
Entry Price
₹2,525
Price@Trade
₹2,521.2
Target Price
₹3,000
Stop Price
₹2,300
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹690,910.8 approx for 1200 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Roop @roop-SkCG4sUYL
Jun 2 2:54 AM

Update
Exited before entry
Price @ Update
₹2,523.95
Reputation: 158 • Jun 2 2:36 AM

DIVISLAB - chart - 850072
#ChartArt #EducationalPurposes #DIVISLAB
#Bullish CMP 2480
1
Reply
R
Reputation: 3,404 • Jun 1 12:08 PM

View: expecting 2950-3000 level ..
Cmp : 2486 #DIVISLAB
Like
Reply
somiish shukkla in DIVISLAB
#DIVISLAB low made 2386 to 2390 2424 wld see if...

#DIVISLAB again low made 2360 and from our buy level 2371 to 2460 to 2480 all target done on buy side
Like
Reply
somiish shukkla in DIVISLAB
#DIVISLAB is good to buy above 2371 for 2390, ...

#DIVISLAB low made 2386 to 2390 2424 wld see if it closes above 2445 or not 9:51 / 01-June
Like
Reply

DIVISLAB - chart - 845205
#DIVISLAB In a Triangle Breakout,
Minimum Price Objective Would Be 2450-2500. But Prices Are More Likely To Go Beyond Them, If the Move Is Strong.
2
Reply (4)
Latest replies
Paras @paras-HJlknZOQ8
May 31 1:49 AM

Hey sir can you do analysis of Equitas holding!
Paras @paras-HJlknZOQ8
May 31 1:49 AM

I bought at 42.75
ElliottWave Master @ygtrader
May 31 2:08 AM
Paras @paras-HJlknZOQ8
May 31 3:12 AM

Thank you

DIVISLAB - chart - 845029
#DIVISLAB is good to buy above 2371 for 2390, 2413, close above this for 2445. Sell only below 2351
Like
Reply
Reputation: 13,291 • May 30 10:55 AM

DIVIS LAB: CO TO CONSIDER Q4 RESULT ON 6TH JUNE
Like
Reply
Reputation: 6,544 • May 29 8:26 AM

Type
Sell
Instrument
DIVISLAB JUN20 FUT
Entry Price
₹2,377
Price@Trade
₹2,377.1
Target Price
₹2,220
Stop Price
₹2,445
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹226,912.95 approx for 400 Qty
Status
Exited
Exit Price
₹2,358.5
Net P&L
+₹7,400 (+3.26%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 29 8:28 AM

Update
Trade Entered
Entry Price
₹2,377
HIDDEN GEM @hidden
Jun 1 4:06 AM

Update
Exited
Exit Price
₹2,358.5
Net P&L
+₹7,400 (+3.26%)
Reputation: 15,755 • May 27 5:11 AM

Type
Buy
Instrument
DIVISLAB
Entry Price
₹2,310  ₹2,309
Price@Trade
₹2,309.95
Target Price
₹2,330
Stop Price
₹2,299
Valid Till
May 27, 2020 3:20 AM
Margin
₹923,600 approx for 400 Qty
Status
Exited before entry
Like
Reply (2)
Latest replies
Baddshaah @baddshaah
May 27 5:11 AM

Update
Entry Price Modified
Price @ Update
₹2,310
Original Entry Price
₹2,310
New Entry Price
2309.0
Baddshaah @baddshaah
May 27 5:12 AM

Update
Exited before entry
Price @ Update
₹2,307
T
Reputation: -18,836 • May 27 3:33 AM

Type
Sell
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,270
Price@Trade
₹2,270
Target Price
₹2,250
Stop Price
₹2,290
Valid Till
May 27, 2020 3:20 AM
Margin
₹433,329.2 approx for 400 Qty
Status
Stoploss Hit
Exit Price
₹2,290
Net P&L
-₹8,000 (-1.85%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
May 27 4:42 AM

Update
Stoploss Hit
Exit Price
₹2,290
V
Reputation: 5,254 • May 26 4:49 AM

Type
Buy
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,296
Price@Trade
₹2,296.75
Target Price
₹2,350
Stop Price
₹2,250
Valid Till
May 28, 2020 3:20 AM
Margin
₹213,071.51 approx for 400 Qty
Status
Exited
Exit Price
₹2,315.2
Net P&L
+₹7,680 (+3.6%)
1
Reply (2)
Latest replies
TrackerBot @trackerbot
May 26 5:01 AM

Update
Trade Entered
Entry Price
₹2,296
Vijay @vijay-rkef8aMU4
May 26 6:31 AM

Update
Exited
Exit Price
₹2,315.2
Net P&L
+₹7,680 (+3.6%)

Type
Sell
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,339.15
Price@Trade
₹2,339.15
Target Price
₹2,290
Stop Price
₹2,373  ₹2,353
Valid Till
May 22, 2020 3:20 AM
Margin
₹214,058.16 approx for 400 Qty
Status
Exited
Exit Price
₹2,336.5
Net P&L
+₹1,060 (+0.5%)
Like
Reply (2)
Latest replies
Santosh @santosh-Hyh2gPyPS
May 22 6:14 AM

Update
Stoploss Trailed
Price @ Update
₹2,336.75
Original SL
₹2,373
New SL
2353.0
Santosh @santosh-Hyh2gPyPS
May 22 6:31 AM

Update
Exited
Exit Price
₹2,336.5
Net P&L
+₹1,060 (+0.5%)
Reputation: -464 • May 20 5:09 AM

Type
Sell
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,350
Price@Trade
₹2,344.65
Target Price
₹2,266
Stop Price
₹2,420
Valid Till
May 28, 2020 3:20 AM
Margin
₹216,462.28 approx for 400 Qty
Status
Exited
Exit Price
₹2,310.3
Net P&L
+₹15,880 (+7.34%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 20 6:04 AM

Update
Trade Entered
Entry Price
₹2,350
Fatka007 @fatka007
May 26 2:59 AM

Update
Exited
Exit Price
₹2,310.3
Net P&L
+₹15,880 (+7.34%)
Reputation: -3,636 • May 18 2:50 AM

Type
Buy
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,362
Price@Trade
₹2,363.05
Target Price
₹2,393
Stop Price
₹2,347
Valid Till
May 18, 2020 3:20 AM
Margin
₹218,932.28 approx for 400 Qty
Status
Stoploss Hit
Exit Price
₹2,347
Net P&L
-₹6,000 (-2.74%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 18 2:51 AM

Update
Trade Entered
Entry Price
₹2,362
TrackerBot @trackerbot
May 18 3:04 AM

Update
Stoploss Hit
Exit Price
₹2,347
Reputation: 1,131 • May 15 2:59 AM

15-05-20
DIVISLAB BUY MAY PE 2400 (Intraday)
only Above @ 75 #DIVISLAB
Like
Reply (3)
Latest replies
Sameer  @tradingfab
May 15 3:01 AM

omg too fast.... High 81 🔥🔥🚀🚀 if miss out wait for next opportunity
Sameer  @tradingfab
May 15 3:01 AM

high 89 🔥🔥🚀🚀🚀🚀
Sameer  @tradingfab
May 15 3:11 AM

sorry guys.... typing error... its **DIVISLAB BUY MAY CE 2400** wait for next opportunity
Reputation: 3,010 • May 14 4:28 AM

Type
Buy
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,365
Price@Trade
₹2,365
Target Price
₹2,500
Stop Price
₹2,345  ₹2,368
Valid Till
May 28, 2020 3:20 AM
Margin
₹224,730.2 approx for 400 Qty
Status
Stoploss Hit
Exit Price
2368.0
Net P&L
+₹1,200 (+0.53%)
Like
Reply (3)
Latest replies
Stock Elixir @stockelixir
May 14 6:44 AM

Update
Stoploss Trailed
Price @ Update
₹2,369.35
Original SL
₹2,345
New SL
2366.0
Stock Elixir @stockelixir
May 14 6:49 AM

Update
Stoploss Trailed
Price @ Update
₹2,370.2
Original SL
₹2,366
New SL
2368.0
TrackerBot @trackerbot
May 14 6:50 AM

Update
Stoploss Hit
Exit Price
2368.0

Type
Buy
Instrument
DIVISLAB MAY20 2400 CE
Entry Price
₹57.45
Price@Trade
₹57.45
Target Price
₹75
Stop Price
₹40
Valid Till
May 14, 2020 3:20 AM
Margin
₹22,980 approx for 400 Qty
Status
Exited
Exit Price
₹70.25
Net P&L
+₹5,120 (+22.28%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹70.25
Net P&L
+₹5,120 (+22.28%)
Reputation: -14,233 • May 13 8:42 AM

Type
Buy
Instrument
DIVISLAB MAY20 2340 CE
Entry Price
₹98
Price@Trade
₹96
Target Price
₹120
Stop Price
₹80
Valid Till
May 14, 2020 3:20 AM
Margin
₹39,200 approx for 400 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
MARKET PULSE @marketpulse
May 14 2:50 AM

Update
Exited before entry
Price @ Update
₹96
B
Reputation: -5,798 • May 12 2:58 AM

Type
Buy
Instrument
DIVISLAB MAY20 2350 CE
Entry Price
₹86
Price@Trade
₹85
Target Price
₹100
Stop Price
₹75
Valid Till
May 13, 2020 3:20 AM
Margin
₹68,800 approx for 800 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Brinder Yadav @brinder
May 12 3:35 AM

Update
Exited before entry
Price @ Update
₹78
Reputation: 2,913 • May 11 8:20 AM
Pyramidstock in DIVISLAB
buy divislab cmp 2337 Sl 2299 tgt 2444 #DIVISLAB
Like
Reply
DIVISLAB

Type
Buy
Instrument
DIVISLAB
Entry Price
₹2,337.75
Price@Trade
₹2,337.75
Target Price
₹2,350
Stop Price
₹2,332
Valid Till
May 11, 2020 3:20 AM
Margin
₹233,775 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹2,332
Net P&L
-₹575 (-0.25%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
May 11 7:07 AM

Update
Stoploss Hit
Exit Price
₹2,332
Reputation: 2,913 • May 11 6:41 AM

buy divislab cmp 2337 Sl 2299 tgt 2444 #DIVISLAB
Like
Reply
DIVISLAB MAY20 FUT

Type
Buy
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,328
Price@Trade
₹2,328
Target Price
₹2,375
Stop Price
₹2,306
Valid Till
May 18, 2020 3:20 AM
Margin
₹221,211.84 approx for 400 Qty
Status
Target Achieved
Exit Price
₹2,390
Net P&L
+₹24,800 (+11.21%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
May 13 2:46 AM

Update
Target Achieved
Exit Price
₹2,390

DIVISLAB
Long/Buying:-
If price is sustaining above 2324.10 on hourly charts, also aggressive traders take long positions at or above 2310.25, for targets of 2324.10 and then followed as per mentioned below targets:
T1. 2349.90;
T2. 2364.25;
T3. 2373.05; and
T4. 2401.35(IMP)...
Read more...
Like
Reply
DIVISLAB MAY20 2400 CE

Type
Buy
Instrument
DIVISLAB MAY20 2400 CE
Entry Price
₹70.5
Price@Trade
₹70.5
Target Price
₹140
Stop Price
₹40
Valid Till
May 11, 2020 3:20 AM
Margin
₹282,000 approx for 4000 Qty
Status
Exited
Exit Price
₹72
Net P&L
+₹6,000 (+2.13%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹72
Net P&L
+₹6,000 (+2.13%)
Reputation: 1,131 • May 11 3:34 AM

11-05-20
DIVISLAB BUY MAY CE 2400 (Intraday)
only above @ 69 #DIVISLAB
Like
Reply (4)
Latest replies
Sameer  @tradingfab
May 11 3:53 AM

high 71 🔥🔥🚀🚀
Sameer  @tradingfab
May 11 3:54 AM

high 72 🔥🔥🔥
Sameer  @tradingfab
May 11 4:01 AM

High 72.75 🔥🔥🚀🚀
Sameer  @tradingfab
May 11 4:37 AM

high 74.80 🔥🔥🚀🚀
Reputation: 3,179 • May 9 1:43 AM
Opportunity is pharma is huge, advise investors to invest: Motilal Oswal
As lockdown mode could continue and the government's ability to come out with an aggressive bailout package is limited, it's difficult to make out a case for big upside in the short run.
Moneycontrol
Like
Reply
T
Reputation: 14,670 • May 7 3:14 AM
DIVISLAB

Type
Sell
Instrument
DIVISLAB
Entry Price
₹2,279
Price@Trade
₹2,288.15
Target Price
₹2,261
Stop Price
₹2,295
Valid Till
May 7, 2020 3:20 AM
Margin
₹170,925 approx for 75 Qty
Status
Exited
Exit Price
₹2,263.05
Net P&L
+₹1,196.25 (+0.7%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 7 3:35 AM

Update
Trade Entered
Entry Price
₹2,279
Tulasi @Tulasi9
May 7 7:10 AM

Update
Exited
Exit Price
₹2,263.05
Net P&L
+₹1,196.25 (+0.7%)
Reputation: 12,659 • May 6 7:30 AM
DIVISLAB MAY20 FUT

Type
Buy
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,302.45
Price@Trade
₹2,302.45
Target Price
₹2,350
Stop Price
₹2,270  ₹2,297
Valid Till
May 7, 2020 3:20 AM
Margin
₹214,872.89 approx for 400 Qty
Status
Stoploss Hit
Exit Price
₹2,297
Net P&L
-₹2,180 (-1.01%)
Like
Reply (2)
Latest replies
Trade Hunk @tradehunk
May 6 7:45 AM

Update
Stoploss Trailed
Price @ Update
₹2,298
Original SL
₹2,270
New SL
₹2,297
TrackerBot @trackerbot
May 6 7:52 AM

Update
Stoploss Hit
Exit Price
₹2,297
S
Reputation: -2,006 • May 6 5:39 AM
DIVISLAB MAY20 FUT

Type
Sell
Instrument
DIVISLAB MAY20 FUT
Entry Price
₹2,284
Price@Trade
₹2,284
Target Price
₹2,210
Stop Price
₹2,301
Valid Till
May 13, 2020 3:20 AM
Margin
₹639,586.56 approx for 1200 Qty
Status
Stoploss Hit
Exit Price
₹2,301
Net P&L
-₹20,400 (-3.19%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
May 6 7:18 AM

Update
Stoploss Hit
Exit Price
₹2,301
DIVISLAB

Type
Buy
Instrument
DIVISLAB
Entry Price
₹2,275
Price@Trade
₹2,278.65
Target Price
₹2,300
Stop Price
₹2,250
Valid Till
May 7, 2020 3:20 AM
Margin
₹227,500 approx for 100 Qty
Status
Target Achieved
Exit Price
₹2,300
Net P&L
+₹2,500 (+1.1%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 6 5:42 AM

Update
Trade Entered
Entry Price
₹2,275
TrackerBot @trackerbot
May 6 7:19 AM

Update
Target Achieved
Exit Price
₹2,300
D
Reputation: -35,847 • May 5 3:13 AM
DIVISLAB

Type
Buy
Instrument
DIVISLAB
Entry Price
₹2,317
Price@Trade
₹2,315.15
Target Price
₹2,345
Stop Price
₹2,290
Valid Till
May 5, 2020 3:20 AM
Margin
₹231,700 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹2,290
Net P&L
-₹2,700 (-1.17%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 5 3:14 AM

Update
Trade Entered
Entry Price
₹2,317
TrackerBot @trackerbot
May 5 5:31 AM

Update
Stoploss Hit
Exit Price
₹2,290
Reputation: 635 • May 4 5:10 AM
DIVISLAB

Type
Buy
Instrument
DIVISLAB
Entry Price
₹2,299.15
Price@Trade
₹2,299.15
Target Price
₹3,000
Stop Price
₹2,000
Valid Till
May 4, 2021 3:20 AM
Margin
₹2,299.15 approx for 1 Qty
Status
Exited
Exit Price
₹2,254.95
Net P&L
-₹44.2 (-1.92%)
Like
Reply (1)
Latest replies
kalyan @kalyanm
May 6 3:37 AM

Update
Exited
Exit Price
₹2,254.95
Net P&L
-₹44.2 (-1.92%)
HarmonicsTraders in DIVISLAB
Reversal day for DIVISLAB is Apr 27 based on Ga...

Divis Lab - Bearish Reversal Day Summary as Below 👇🏻👇🏻
Double Top wrt 52 Week High :)
2472 ( 2474 is 52 week High) to 2300
170+ points Done as of now :)
Weekly Top is Got as Well !
Price Action ( PA) Guys Now Say as Divis is falling from Supply Zone but Beloved Gann Students...
Read more...
Like
Reply (2)
Latest replies
Reputation: 3,179 • May 1 5:43 AM
Brokerages recommend these 12 stocks in time of uncertainty; do you own any?
Experts point out that the COVID-19 pandemic came in stages across the world and its fading away also will happen in phases over the next few quarters.
Moneycontrol
Like
Reply
RJ ROCKET TRADES in DIVISLAB
**SELL DIVISLAB BELOW 2400** **TG 2390/2385/237...

**Divis lab gone guys 2360 from 2400**
**All targets met in it**
Like
Reply
RJ ROCKET TRADES in DIVISLAB
**SELL DIVISLAB BELOW 2400** **TG 2390/2385/237...

**Bang on guys divislab t1 hit t2 almost hit**
**Enjoy 2386 from 2400 Till now**
**Expecting it to break more from here**
**Keep booking profits**
Like
Reply
DIVISLAB APR20 FUT

Type
Sell
Instrument
DIVISLAB APR20 FUT
Entry Price
₹2,393
Price@Trade
₹2,393
Target Price
₹2,310
Stop Price
₹2,420
Valid Till
Apr 28, 2020 3:20 AM
Margin
₹1,136,690.2 approx for 2000 Qty
Status
Exited
Exit Price
₹2,386.1
Net P&L
+₹13,800 (+1.21%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹2,386.1
Net P&L
+₹13,800 (+1.21%)

**SELL DIVISLAB BELOW 2400**
**TG 2390/2385/2370**
**SL 2411**
Like
Reply
DIVISLAB APR20 FUT

Type
Buy
Instrument
DIVISLAB APR20 FUT
Entry Price
₹2,431
Price@Trade
₹2,430.45
Target Price
₹2,445
Stop Price
₹2,421
Valid Till
Apr 27, 2020 3:20 AM
Margin
₹458,233.36 approx for 800 Qty
Status
Exited
Exit Price
₹2,437.7
Net P&L
+₹5,360 (+1.17%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Apr 27 6:04 AM

Update
Trade Entered
Entry Price
₹2,431

Update
Exited
Exit Price
₹2,437.7
Net P&L
+₹5,360 (+1.17%)
Reputation: 3,179 • Apr 27 5:08 AM
Nifty rejig: D-Mart, HDFC Life and SBI Life among front runners that could be included
Stocks which are likely to be excluded from the Nifty50 are Bharti Infratel, Vedanta, Zee Entertainment, Tata Motors and GAIL India, ICICI Direct feels.
Moneycontrol
Like
Reply
Reputation: -14,233 • Apr 27 3:12 AM
DIVISLAB APR20 2450 CE

Type
Buy
Instrument
DIVISLAB APR20 2450 CE
Entry Price
₹58
Price@Trade
₹55.35
Target Price
₹80
Stop Price
₹40
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹23,200 approx for 400 Qty
Status
Stoploss Hit
Exit Price
₹40
Net P&L
-₹7,200 (-31.03%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Apr 27 3:31 AM

Update
Trade Entered
Entry Price
₹58
TrackerBot @trackerbot
Apr 27 4:27 AM

Update
Stoploss Hit
Exit Price
₹40

Reversal day for DIVISLAB is Apr 27 based on Gann method
Like
Reply
Like
Reply
Reputation: 1,420 • Apr 24 6:15 AM

*RISKY A BIT --- BUY DIVISLAB 2500CE AROUND 36-38 - SL 32 BREAK - TARGET OPEN*
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • DIVISLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization45,211.44
    Enterprise Value45,212.24
    Price to Earnings33.24
    Price to Book Value6.48
    Return on Capital Employed0.2
    Return on Equity0.15
    Face Value2
    Dividend Yield0.01
  • DIVISLAB - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    20-Feb-20SharekhanBuy2,430
    19-Aug-19SharekhanBuy1,800
    12-Aug-19Karvy Stock BrokingHold1,744
    28-May-19ICICIdirect.comHold1,780
    4-Feb-19ICICIdirect.comBuy1,800
    DIVISLAB Brokerage Price Target
  • DIVISLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jun 52429.4524762415.752460.05
    Jun 42392243923852421.15
    Jun 3242024422367.22382.2
    Jun 225002537.9524002411
    Jun 12402.12492.923602480.05
  • DIVISLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,357.52
    30 Day Moving Average₹2,353.55
    50 Day Moving Average₹2,257.03
    100 Day Moving Average₹2,130.94
    200 Day Moving Average₹1,917.83
  • DIVISLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3,8164,023.47-0.05
    Operating Profit1,2521,438.85-0.13
    Profit Before Tax1,2191,388.23-0.12
    Net Income8701,053.27-0.17
  • DIVISLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds6,9735,9600.17
    Total Liabilities1,0678610.24
    Total Assets8,0406,8210.18
  • DIVISLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity7651,148.05-0.33
    Cash from Investing Activity-476-1,134.08-0.58
    Cash from Financing Activity-314-9.3132.73
    Net Cash Flow-254.66-6.36
  • DIVISLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.130.17
    Return on Equity0.150.19
    Return on Capital Employed0.20.26
  • DIVISLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.24
    3 Year CAGR Growth in Operating Profit0.08
    3 Year CAGR Growth in EBIDTA0.13
    3 Year CAGR Growth in Net Income0.03
    3 Yr CAGR Growth - Diluted EPS-0.49
  • DIVISLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.79
    5 Year CAGR Growth in Operating Profit0.52
    5 Year CAGR Growth in EBIDTA0.57
    5 Year CAGR Growth in Net Income0.42
    3 Yr CAGR Growth - Diluted EPS-0.29
  • DIVISLAB - Recent News

    keyboard_arrow_down
    NewsBot
    May 9 1:43 AM
    Opportunity is pharma is huge, advise investors to invest: Motilal Oswal
    Moneycontrol
    NewsBot
    May 1 5:43 AM
    Brokerages recommend these 12 stocks in time of uncertainty; do you own any?
    Moneycontrol
    NewsBot
    Apr 27 5:08 AM
    Nifty rejig: D-Mart, HDFC Life and SBI Life among front runners that could be included
    Moneycontrol
    NewsBot
    Apr 16 4:13 AM
    COVID-19 lockdown extended: These 8 stocks could help investors weather the storm
    Moneycontrol
    NewsBot
    Mar 17 6:43 AM
    Investors should understand businesses are not doing bad: Gaurav Garg
    Moneycontrol
    NewsBot
    Mar 9 5:28 AM
    Divi's Laboratories begins commercial production at Visakhapatnam unit
    Moneycontrol
    NewsBot
    Feb 24 7:43 AM
    Brokerages see Sensex around 43,650 in a year; top investment ideas post Q3
    Moneycontrol
    NewsBot
    Feb 24 7:38 AM
    Brokerages see Nifty around 13,350 & Sensex around 43,650 in a year; 10 investment ideas
    Moneycontrol
    NewsBot
    Feb 24 4:13 AM
    Buy Divis Laboratories target of Rs 2430: Sharekhan
    Moneycontrol
    NewsBot
    Feb 10 9:23 AM
    Buy Divi’s Laboratories target of Rs 2200: Sharekhan
    Moneycontrol
  • DIVISLAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Apollo Hospitals Enterprise Ltd. NSE:...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
  • DIVISLAB - More Information

    keyboard_arrow_down

    Divi's Laboratories Ltd:
    Divi's Laboratories Limited is incorporated back in 1990 and headquartered in Hyderabad, Telangana, India. This company, at its initial stage of the foundation, was named as Divi's Research Centre and later on in 1994 was changed to Divi's Laboratories Limited. This company is responsible for manufacturing and selling APIs or active pharmaceutical ingredients along with intermediates for generics. This is carried on in India, other parts of Asia, US, Europe and several other parts of the world.
    It offers the different unit for building compounds like several carotenoids inclusive of beta-carotene, astaxanthin, canthaxanthin, lycopene, and apocarotenol. Other than this it also offers groups for building protects amino acids like FMOC, BCZ and BOC as well as for chiral ligands and peptide and nucleotides.
    Apart from this, it also customizes the synthesis of several active pharmaceutical ingredients along with advanced forms of discovered compounds for other pharmaceutical companies. It also offers full-time contract-based research on development processes to identify new compounds.
    Company Information:
    Between the years 1991-1993, Divi's developed multiple bulk actives and other intermediates products for several other manufacturing companies. It received its ISO-9002 certification with compliance to SGS-Yarsley belonging to the UK, back in 1997. With the following two years, in 1999, the company received a Certificate of Suitability from the European Directorate for the production of Naproxen.
    For the company's system of occupational health and safety management, it received the OHSAS-18001 certificate. It was given to them by BVQI from London in 2001. In the year 2002, Divi's set up their Unit number II, a manufacturing facility in Chippada. In the following year in 2003, the company inaugurated a new research centre in Vizag, named DRC-Vizag. This was built for fundamental research in specific core segments.
    In the year 2004, Rs 3035.21 lakh was invested by Divi's for adding machines to both of their units in Unit-I (Choutuppal) and Unit-II (Chippada), and this was accounted for in their capital expenditure. In 2006, it received an approval letter from the Ministry of Commerce in India. This was for setting up a Special Economic Zone for multiple pharma based ingredients at Chippada, Vizag which led the company to invest Rs 200 crore.
    During the year 2008-09, the company's portfolio added a total of 9 products. Four of these nine products consisted of generic APIs, and the rest belonged to intermediates and custom synthesis of APIs. Another seven products were added to the company portfolio in 2009-2010. Out of these seven products, 2 were generic APIs along with intermediates, while the rests were intermediates and custom synthesis APIs. During the year 2012-13, the company went on to add another nine products out of which three of these were generic APIs along with intermediates, and the rest six were custom synthesis APIs and intermediates.
    On 19 February 2016, the company went through an inspection by US-FDA for its second unit in Chapada, Bhemunipatam near Vizag and was this event was successful which happened without any observation. In 2017, on 18 November, the company announced that it had received EIR (Establishment Inspection Report) from FDA (US) for their second unit in Vizag. On 16 May 2018, Divi's Laboratories stated that their Unit-I in Telangana was under the inspection of the US-FDA starting from 14 May 2018 to 16 May 2018. The review conducted was a cGMP general inspection done by the FDA.
    The company is one of the biggest pharmaceutical companies in the country, which currently has a portfolio of 120 products. It has presently products belonging to multiple therapeutic aspects. It has a total of four manufacturing units with a developing market presence in several countries. Their first facility is located in Yadadri Bhuvanagiri District; Telangana consists of 11 blocks for multipurpose production along with finishes product spaces for APIs.
    How Divi’s Laboratories, is categorised as a Pharmaceutical and Health care Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Divi's Laboratories is categorized under the Pharmaceutical and Health care sector and Pharmaceutical Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Divi’s Laboratories, Competitors and Sector Peers:
    Abbott India Ltd. ABBIND
    Alembic Ltd. ALELTD
    Alembic Pharmaceuticals Ltd. ALEPHA
    Alkem Laboratories Ltd. ALKLAB
    Alpa Laboratories Ltd. ALPLAB
    Ambalal Sarabhai Enterprises Ltd. AMBSAR
    AstraZeneca Pharma India Ltd. ASTZEN
    Bafna Pharmaceuticals Ltd. BAFPHA
    Bajaj Healthcare Ltd. BAJHEA
    Biocon Ltd. BIOLTD
    Cian Healthcare Ltd.
    Cipla Ltd. CIPLTD
    Concord Drugs Ltd. CONDRU
    Dishman Pharmaceuticals & Chemicals Ltd.[Merged] DISPHA
    Divi's Laboratories Ltd. DIVIL
    Dr. Reddy's Laboratories Ltd. DR
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    Lincoln Pharmaceuticals Ltd. LINPHA
    Lupin Ltd. LUPLTD
    Madhuveer Com 18 Network Ltd. TOHPHA
    Mahavir Advanced Remedies Ltd. INDAME
    Makers Laboratories Ltd. MAKLAB
    Natco Pharma Ltd. NATPHA
    Natural Capsules Ltd. NATCAP
    Ranbaxy Laboratories Ltd. RANLAB
    Sanofi India Ltd. AVEPHA
    Sharon Bio-Medicine Ltd. SHAPHA
    Sun Pharmaceutical Industries Ltd. SUN28
    Zenith Healthcare Ltd. ZENHEA
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020